Definium Therapeutics Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$17.79

-0.31 (-1.71%)

As of Mar 24, 10:02 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 20 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +158.6% upside

Low Target $39.37

Average Target $46.00

High Target $57.04

Current Price $17.79

Current
$17.79

Target
$46.00

$39.37 $46.00 avg $57.04

Scenario Analysis

Bear Case

$39.37

121.3%

Low target

Base Case

$46.00

+158.6%

Avg target

Bull Case

$57.04

+220.6%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$18.70

-4.9% from high

52-Week Low

$14.62

+21.7% from low

Target vs 52W High

$46.00

+146.0% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%